+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Resorbable Vascular Scaffold Market by Indication (Coronary Artery Disease, Peripheral Arterial Disease), Material (Magnesium, Polylactic Acid), End User, Scaffold Diameter, Scaffold Length - Global Forecast 2025-2030- Product Image
Resorbable Vascular Scaffold Market by Indication (Coronary Artery Disease, Peripheral Arterial Disease), Material (Magnesium, Polylactic Acid), End User, Scaffold Diameter, Scaffold Length - Global Forecast 2025-2030- Product Image
Sale

Resorbable Vascular Scaffold Market by Indication (Coronary Artery Disease, Peripheral Arterial Disease), Material (Magnesium, Polylactic Acid), End User, Scaffold Diameter, Scaffold Length - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012364
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The resorbable vascular scaffold market is advancing rapidly as healthcare systems demand innovative, patient-centric interventional cardiology solutions. This shift is spurred by ongoing improvements in scaffold materials and deployment techniques, offering attractive growth opportunities for industry leaders within a transforming regulatory and clinical environment.

Market Snapshot: Resorbable Vascular Scaffold Market Growth

The resorbable vascular scaffold market grew from USD 576.57 million in 2024 to USD 656.95 million in 2025. It is projected to sustain a CAGR of 13.82%, reaching USD 1.25 billion by 2030. This upward trajectory reflects adoption driven by rising demand for minimally invasive therapies and ongoing advancements in device technology. Regulatory evolution and increased collaboration among manufacturers, clinicians, and payers are strengthening market confidence, fostering rapid uptake of resorbable solutions globally.

Scope & Segmentation

This comprehensive report delivers detailed analysis across key segments and regions, helping senior decision-makers identify and capture growth opportunities. The report examines:

  • Indications: Coronary artery disease, acute coronary syndrome, stable angina, peripheral arterial disease, claudication, and critical limb ischemia
  • Material Types: Magnesium-based scaffolds, polylactic acid constructs
  • End Users: Ambulatory surgical centers, cardiac centers, hospitals
  • Scaffold Diameters: Vessels less than three millimeters, three millimeters and above
  • Scaffold Lengths: Less than eighteen millimeters, eighteen to twenty-eight millimeters, greater than twenty-eight millimeters
  • Regions: Americas (including United States, Brazil, Argentina, Canada, Mexico), EMEA (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Terumo Corporation, Meril Life Sciences Private Limited, Elixir Medical Corporation, Xeltis AG, Cardionovum GmbH, MicroPort Scientific Corporation, Zorion Medical

Key Takeaways for Decision-Makers

  • Resorbable vascular scaffolds are positioned to address the limitations found in traditional metallic stents, offering temporary vessel support with natural degradation for improved patient outcomes.
  • Continuous improvements in material science, such as the utilization of magnesium and advanced polymers, are optimizing device performance and broadening clinical applications.
  • Collaboration across multidisciplinary teams ensures evidence-based patient selection, enhances procedural success, and streamlines integration into existing treatment pathways.
  • Strategic alliances, including R&D partnerships, licensing, and mergers, are enabling companies to scale innovation and reinforce their presence in interventional cardiology portfolios.
  • Regional market dynamics reflect varying levels of adoption, with developed regions leading clinical validation and emerging markets accelerating adoption through local partnerships and cost-control strategies.

Tariff Impact and Supply Chain Adaptation

Revised United States tariff policies in 2025 have influenced raw material sourcing and manufacturing costs throughout the resorbable vascular scaffold market. In response, manufacturers are reassessing production footprints, forming regional partnerships, embracing vertical integration, and optimizing operational processes. These measures are enhancing supply chain resilience and allowing for more flexible pricing, despite increased regulatory complexity and procurement challenges.

Methodology & Data Sources

Findings in this report are supported by a multi-tiered research approach, combining primary interviews with clinical leaders, manufacturers, and supply chain experts, with secondary analysis of peer-reviewed journals, regulatory filings, corporate announcements, and clinical trial registries. Data triangulation and domain expert validation underpin the integrity of strategic insights provided.

Why This Report Matters

  • Enables executive teams to identify actionable strategies in evolving global markets using up-to-date, expert-driven market intelligence.
  • Supports supply chain, R&D, and commercial leaders in scenario planning for regulatory changes, tariff shifts, and competitive partnerships.
  • Facilitates informed decision-making by providing comprehensive, segmented views of regional and technology-driven market trends.

Conclusion

Senior decision-makers seeking clear direction in the resorbable vascular scaffold market will benefit from this report’s detailed segmentation, strategic guidance, and insights into regional growth factors. These findings support rigorous planning and opportunity capture in a competitive, innovation-driven landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging bioresorbable magnesium scaffold prototypes offering enhanced mechanical support and controlled degradation kinetics
5.2. Integration of intravascular imaging technologies to optimize scaffold placement and minimize malapposition risks
5.3. Comparative long term clinical outcomes of polymer based versus metallic bioresorbable scaffold platforms
5.4. Cost utility analyses assessing total treatment cost and quality adjusted life years gained with bioresorbable scaffolds
5.5. Accelerated regulatory approvals in Asia Pacific driving adoption of next generation resorbable scaffold devices
5.6. Development of dual therapy scaffolds delivering antiproliferative drugs alongside gene therapy vectors for restenosis prevention
5.7. Personalized scaffold designs based on patient specific coronary anatomy using advanced 3D printing and imaging data
5.8. Sustainability impact of biodegradation byproducts on vascular healing and systemic inflammatory response profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Resorbable Vascular Scaffold Market, by Indication
8.1. Introduction
8.2. Coronary Artery Disease
8.2.1. Acute Coronary Syndrome
8.2.2. Stable Angina
8.3. Peripheral Arterial Disease
8.3.1. Claudication
8.3.2. Critical Limb Ischemia
9. Resorbable Vascular Scaffold Market, by Material
9.1. Introduction
9.2. Magnesium
9.3. Polylactic Acid
10. Resorbable Vascular Scaffold Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Cardiac Centers
10.4. Hospitals
11. Resorbable Vascular Scaffold Market, by Scaffold Diameter
11.1. Introduction
11.2. Less Than 3 Millimeter
11.3. Three Millimeter And Above
12. Resorbable Vascular Scaffold Market, by Scaffold Length
12.1. Introduction
12.2. Eighteen To Twenty Eight Millimeter
12.3. Greater Than Twenty Eight Millimeter
12.4. Less Than Eighteen Millimeter
13. Americas Resorbable Vascular Scaffold Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Resorbable Vascular Scaffold Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Resorbable Vascular Scaffold Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Boston Scientific Corporation
16.3.3. Biotronik SE & Co. KG
16.3.4. Terumo Corporation
16.3.5. Meril Life Sciences Private Limited
16.3.6. Elixir Medical Corporation
16.3.7. Xeltis AG
16.3.8. Cardionovum GmbH
16.3.9. MicroPort Scientific Corporation
16.3.10. Zorion Medical
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RESORBABLE VASCULAR SCAFFOLD MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RESORBABLE VASCULAR SCAFFOLD MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RESORBABLE VASCULAR SCAFFOLD MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RESORBABLE VASCULAR SCAFFOLD MARKET: RESEARCHAI
FIGURE 26. RESORBABLE VASCULAR SCAFFOLD MARKET: RESEARCHSTATISTICS
FIGURE 27. RESORBABLE VASCULAR SCAFFOLD MARKET: RESEARCHCONTACTS
FIGURE 28. RESORBABLE VASCULAR SCAFFOLD MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RESORBABLE VASCULAR SCAFFOLD MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STABLE ANGINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CLAUDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MAGNESIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN 3 MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY THREE MILLIMETER AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY EIGHTEEN TO TWENTY EIGHT MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GREATER THAN TWENTY EIGHT MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY LESS THAN EIGHTEEN MILLIMETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 90. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 91. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 92. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 93. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 94. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 95. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 98. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 99. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 100. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 101. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 106. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 107. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 109. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 114. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 173. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 176. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 177. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 178. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 179. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 180. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 181. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 184. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 185. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 186. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 187. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 190. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 191. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 192. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 193. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 194. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 195. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 198. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 199. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 200. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 215. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 218. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 219. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 220. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 221. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 222. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 223. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 226. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 227. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 228. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 229. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 232. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 233. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 234. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 235. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 236. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 237. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 240. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 241. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 242. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 285. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 288. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2025-2030 (USD MILLION)
TABLE 289. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2018-2024 (USD MILLION)
TABLE 290. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, 2025-2030 (USD MILLION)
TABLE 291. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 292. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 293. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2018-2024 (USD MILLION)
TABLE 296. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD DIAMETER, 2025-2030 (USD MILLION)
TABLE 297. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2018-2024 (USD MILLION)
TABLE 298. DENMARK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY SCAFFOLD LENGTH, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTER

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Meril Life Sciences Private Limited
  • Elixir Medical Corporation
  • Xeltis AG
  • Cardionovum GmbH
  • MicroPort Scientific Corporation
  • Zorion Medical

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 656.95 Million
Forecasted Market Value ( USD ) by 2030 $ 1250 Million
Compound Annual Growth Rate13.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Resorbable Vascular Scaffolds Global Market Report 2025 - Product Image

Resorbable Vascular Scaffolds Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Bioresorbable Vascular Scaffold Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 195 Pages
  • Global
From
Bioresorbable Vascular Scaffolds - Global Strategic Business Report - Product Image

Bioresorbable Vascular Scaffolds - Global Strategic Business Report

  • Report
  • 265 Pages
  • Global
From
Mg Alloy Vascular Scaffold Market by Scaffold Type (Bare, Bioactive, Drug Eluting), Application (Coronary, Neurovascular, Peripheral), End User, Coating, Deployment Mechanism - Global Forecast 2025-2030 - Product Image

Mg Alloy Vascular Scaffold Market by Scaffold Type (Bare, Bioactive, Drug Eluting), Application (Coronary, Neurovascular, Peripheral), End User, Coating, Deployment Mechanism - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
PLA Vascular Scaffold Market by Application (Coronary Artery Disease, Peripheral Artery Disease), Product Type (Balloon Expandable Scaffold, Self Expandable Scaffold), End User, Diameter, Length, Material Grade, Sterilization Method - Global Forecast 2025-2030 - Product Image

PLA Vascular Scaffold Market by Application (Coronary Artery Disease, Peripheral Artery Disease), Product Type (Balloon Expandable Scaffold, Self Expandable Scaffold), End User, Diameter, Length, Material Grade, Sterilization Method - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From

About the Resorbable Vascular Scaffold Market

The Resorbable Vascular Scaffold (RVS) market is a segment of the Cardiovascular Devices industry. RVS are medical devices used to treat coronary artery disease, a condition caused by the narrowing of the arteries that supply blood to the heart. RVS are designed to be implanted in the artery and gradually dissolve over time, allowing the artery to return to its natural state. This technology has been shown to reduce the risk of restenosis, a condition in which the artery becomes narrowed again after treatment. RVS are becoming increasingly popular due to their ability to reduce the risk of restenosis and the fact that they do not require a second procedure to remove the device. Additionally, RVS are less invasive than traditional stents, which require a larger incision and a longer recovery time. Some companies in the RVS market include Abbott, Biotronik, Boston Scientific, Medtronic, and Terumo. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.